Singapore Airlines adds new pharma product to its offering for cargo customers
Sep 21, 2018: Singapore Airlines (SIA) has launched THRUCOOL, a new service to transport high-value, time-sensitive and temperature-controlled pharmaceutical cargo with speed and reliability.
With the introduction of THRUCOOL, the carrier offers dedicated cold chain services to safeguard the integrity of pharmaceutical and healthcare shipments during air transportation. These include priority uplift and handling, quick ramp transfers at airports, cold room facilities, as well as thermal blankets and covers for crucial insulation from external factors.
Adding to it, the airline said, “Customers can also opt to place shipments in temperature-controlled containers, and track their location during shipping.”
In order to ensure further product integrity in cold chain handling both on the ground and in the air, SIA has partnered with leading terminal operators SATS, Cargologic and Qantas Freight to launch a ‘quality corridor’ along the Zurich-Singapore-Sydney route as an initial offering.
Complying with standards adopted from the IATA CEIV Pharma1 programme, the quality corridor addresses the industry’s need for safety, care and efficiency in the transportation of pharmaceutical and healthcare products. This reduces the potential for product loss attributed to handling and environmental factors such as temperature excursions during carriage.
Chin Yau Seng, senior vice president Cargo, SIA said: “We are acutely aware of the life-saving role these shipments play in societies across the world and THRUCOOL is our assurance that our customers’ cargo will receive the best care not only on our flights but also on the ground during transit. We will continue to collaborate with our industry partners to expand our network of quality corridors to further promote the integrity of pharmaceutical products in their journey across key trade lanes.”
SIA was the first airline in the Asia-Pacific region to be awarded the IATA CEIV Pharma Certification and is part of international and regional CEIV communities such as Pharma@Changi, and Pharma.Aero, which jointly pursue innovation in the shipping of pharmaceuticals.
You may also like:-
Otávio joined LATAM Airlines Group in 2015, initially working in cargo planning and commercial areas but since 2019, he was LATAM Cargo Brazil’s Operations vice president.
The large amount of high dense engineering goods, destined for Europe & North America, that made the difference on weight.
The CMA CGM Group investment will result from the combination of a subscription to a capital increase for an amount of 50 million euros and the acquisition of shares.
IATA’s director general and CEO Alexandre de Juniac said that when the AGM was postponed from June to November, they hoped that government restrictions on travel would be eased but that is now unlikely.
The addition of the five points will expand the Emirates' global network to 92 destinations, as the airline gradually resumes its operations while prioritising the safety of its customers, crew and the communities it serves around the world.
Edmonton International Airport (EIA) has partnered with GLC Medical, a subsidiary of Graphene Leaders Canada (GLC), to host clinical trials of a new technology for Covid-19 testing that can produce results in seconds.
While Astral Aviation will be a new Full Member, Bombelli Airport Equipment will come on board as an Associate Partner.
Continuing its technological investments, the software reduces the error rate at its business processes as well as the costs while improving the employee productivity among other aspects
SEOSAT-Ingenio is the first Spanish satellite with optical technology, developed primarily by the Spanish space industry led by Airbus in Spain as the prime contractor.
Weekly direct flights will depart from Shanghai (PVG) every Monday and from Amsterdam (AMS) each Sunday to service for a post-COVID resurgence in demand during what is traditionally a fourth quarter peak season.
Amsterdam Airport Schiphol’s Pharma Cargo Community is collaborating to ensure the temperature-controlled supply chain is ready for the safe and efficient transportation of Covid-19 vaccines.
Through this partnership, Matternet will conduct a joint research project with JAL in Japan, as the company continues to expand its commercial business globally.